Barely Significant
← all excerpts

Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans.

Front Allergy · 2022 · PMC8974761 · PMID 35386649

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
In both 10- and 20-μg treatment groups, the differences of bee venom-specific IgE titers measured at the six consecutive visits were highly significant ( Figure 4B ; p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.